Matches in DBpedia 2016-04 for { ?s ?p "Continuous erythropoietin receptor activator (CERA) is the generic term for drugs in a new class of third-generation erythropoiesis-stimulating agents (ESAs). In the media, these agents are commonly referred to as 'EPO', short for erythropoietin. CERAs have an extended half-life and a mechanism of action that promotes increased stimulation of erythropoietin receptors compared with other ESAs.Under the trade name Mircera, Roche Pharmaceuticals received approval from the U.S."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Continuous_erythropoietin_receptor_activator comment "Continuous erythropoietin receptor activator (CERA) is the generic term for drugs in a new class of third-generation erythropoiesis-stimulating agents (ESAs). In the media, these agents are commonly referred to as 'EPO', short for erythropoietin. CERAs have an extended half-life and a mechanism of action that promotes increased stimulation of erythropoietin receptors compared with other ESAs.Under the trade name Mircera, Roche Pharmaceuticals received approval from the U.S.".
- Q2914445 comment "Continuous erythropoietin receptor activator (CERA) is the generic term for drugs in a new class of third-generation erythropoiesis-stimulating agents (ESAs). In the media, these agents are commonly referred to as 'EPO', short for erythropoietin. CERAs have an extended half-life and a mechanism of action that promotes increased stimulation of erythropoietin receptors compared with other ESAs.Under the trade name Mircera, Roche Pharmaceuticals received approval from the U.S.".